Ondine Biomedical: Funding, Investors & Team (Sep 2026)
Ondine Biomedical Inc., previously known as Ondine Biopharma Corporation, is committed to developing treatments for various bacterial, viral, and fungal infections that do not rely on antibiotics. The company's primary focus is on their patented light-activated technology called Photodisinfection (PDD), which has multiple applications. PDD offers effective antimicrobial properties without promoting the development and spread of antibiotic resistance. In 2006, Ondine Biomedical Inc. introduced their first PDD product called Periowave™, designed as an additional therapy for chronic adult periodontitis (gum disease). In June 2009, Ondine sold its Dental Healthcare Business to PDT Inc.
Ondine Biomedical has raised $15.1M across 2 funding rounds on record, the most recent an undisclosed round of $11.6M announced in Nov 2024.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Ondine Biomedical Company Profile and Key Stats
Latest funding round on record: Nov 2024.
Ondine Biomedical Funding Rounds
Ondine Biomedical raised $3.5M in an undisclosed round announced in Dec 2023.
11 months later, an undisclosed round of $11.6M was announced in Nov 2024.
Ondine Biomedical Founders and Leadership Team
Contact details for the Ondine Biomedical team: 1 of 1 has an email address on file.
Start 14-day free trial →Ondine Biomedical Funding Compared to Other Biotechnology Startups
Ondine Biomedical's latest round of $11.6M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Ondine Biomedical in Biotechnology and Vancouver
Companies Similar to Ondine Biomedical
Medicenna is a clinical-stage immunotherapy company focused on oncology and the development and…
Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective…
Hemostemix Inc. is a Canadian biotechnology company that specializes in creating blood-derived cell therapies…
Avicanna is an organization in the biopharmaceutical sector that concentrates on enhancing medical cannabis…
Edesa Biotech is a privately-held company in the clinical stage that specializes in creating therapies for…
ME Therapeutics is a biotech company that specializes in finding and creating drugs for immuno-oncology that…
Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and…
Medicus Pharma is a biotechnology research company that fast-tracks the progress of life sciences and…
ProteinQure is a biotechnology company specializing in creating innovative peptides for various medical…
Anodyne's mission is to create critical chemicals sustainably. Anodyne's approach takes advantage of nature's…
NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and…
ZYUS is a biopharmaceutical company focused on providing patients with cannabinoids and other plant-based…
Ondine Biomedical Funding FAQs
What does Ondine Biomedical do?
Ondine Biomedical Inc., previously known as Ondine Biopharma Corporation, is committed to developing treatments for various bacterial, viral, and fungal infections that do not rely on antibiotics. The company's primary focus is on their patented light-activated technology called Photodisinfection (PDD), which has multiple applications. PDD offers effective antimicrobial properties without promoting the development and spread of antibiotic resistance. In 2006, Ondine Biomedical Inc. introduced their first PDD product called Periowave™, designed as an additional therapy for chronic adult periodontitis (gum disease). In June 2009, Ondine sold its Dental Healthcare Business to PDT Inc.
How much funding has Ondine Biomedical raised?
Ondine Biomedical has raised $15.1M across 2 rounds on record. The most recent is an undisclosed round of $11.6M announced in Nov 2024.
When did Ondine Biomedical last raise funding?
Ondine Biomedical's most recent funding round on record is an undisclosed round of $11.6M, announced in Nov 2024.
Who founded Ondine Biomedical?
FundedIQ lists Carolyn Cross (Founder) at Ondine Biomedical.
Where is Ondine Biomedical headquartered?
Ondine Biomedical is based in Vancouver, British Columbia, Canada.
How many employees does Ondine Biomedical have?
Ondine Biomedical is in the 11-50 employee band.
How does Ondine Biomedical's funding compare to other Biotechnology startups?
Ondine Biomedical's latest round of $11.6M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's Ondine Biomedical Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Ondine Biomedical is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.